Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosisMARTINEZ, M; LOPEZ-RIBOT, J. L; KIRKPATRICK, W. R et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 49, Num 3, pp 515-524, issn 0305-7453Article

Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditionsKIRKPATRICK, W. R; LOPEZ-RIBOT, J. L; MCATEE, R. K et al.Journal of clinical microbiology (Print). 2000, Vol 38, Num 2, pp 902-904, issn 0095-1137Article

Amphotericin B use in a community hospital, with special emphasis on side effects. Author's replyPATHAK, A; PIEN, F. D; CARVALHO, L et al.Clinical infectious diseases. 1998, Vol 26, Num 2, pp 334-340, issn 1058-4838Article

Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicansPATTERSON, T. F; KIRKPATRICK, W. R; REVANKAR, S. G et al.Journal of clinical microbiology (Print). 1996, Vol 34, Num 12, pp 3237-3239, issn 0095-1137Article

The role of liposomal amphotericin B in the treatment of systemic fungal infectionsPATTERSON, T. F; ANDRIOLE, V. T.European journal of cancer & clinical oncology. 1989, Vol 25, pp S63-S68, issn 0277-5379, suppl. 2Article

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental modelPATTERSON, T. F; MINITER, P; RYAN, J. L et al.The Journal of infectious diseases. 1988, Vol 158, Num 2, pp 415-422, issn 0022-1899Article

Efficacy of SCH56592 in a rabbit model of invasive aspergillosisKIRKPATRICK, W. R; MCATEE, R. K; FOTHERGILL, A. W et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 3, pp 780-782, issn 0066-4804Article

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients : Clinical outcomes and development of fluconazole resistanceREVANKAR, S. G; KIRKPATRICK, W. R; MCATEE, R. K et al.The American journal of medicine. 1998, Vol 105, Num 1, pp 7-11, issn 0002-9343Article

Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards methodREVANKAR, S. G; KIRKPATRICK, W. R; MCATEE, R. K et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 1, pp 153-156, issn 0095-1137Article

Opening the operating window of impulse drying-Part II: Pressure differential as a source of delaminationORLOFF, D. I; PATTERSON, T. F; PARVIAINEN, P. M et al.Tappi journal. 1998, Vol 81, Num 8, pp 195-203, issn 0734-1415Article

Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine : a randomized, double-blind clinical trialSPRUANCE, S. L; PAVIA, A. T; MOREY, G. E et al.Annals of internal medicine. 1994, Vol 120, Num 5, pp 360-368, issn 0003-4819Article

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosisPATTERSON, T. F; GEORGE, D; MINITER, P et al.The Journal of infectious diseases. 1991, Vol 164, Num 3, pp 575-580, issn 0022-1899Article

Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalisPATTERSON, J. E; PATTERSON, T. F; FARREL, P et al.Journal of clinical microbiology (Print). 1989, Vol 27, Num 5, pp 944-946, issn 0095-1137Article

Don't throw your blood clots away: use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosisMCCULLOCH, E; RAMAGE, G; JONES, B et al.Journal of clinical pathology. 2009, Vol 62, Num 6, pp 539-541, issn 0021-9746, 3 p.Article

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsREVANKAR, S. G; DIB, O. P; KIRKPATRICK, W. R et al.Clinical infectious diseases. 1998, Vol 26, Num 4, pp 960-963, issn 1058-4838Article

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsREVANKAR, S. G; KIRKPATRICK, W. R; MCATEE, R. K et al.The Journal of infectious diseases. 1996, Vol 174, Num 4, pp 821-827, issn 0022-1899Article

Systematics of Mexican spruce: revisitedTAYLOR, R. J; PATTERSON, T. F; HARROD, R. J et al.Systematic botany. 1994, Vol 19, Num 1, pp 47-59, issn 0363-6445Article

Saperconazole therapy in a rabbit model of invasive aspergillosisPATTERSON, T. F; GEORGE, D; MINITER, P et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 12, pp 2681-2685, issn 0066-4804Article

Epidemiology, natural history, and management of urinary tract infections in pregnancyANDRIOLE, V. T; PATTERSON, T. F.The Medical clinics of North America. 1991, Vol 75, Num 2, pp 359-373, issn 0025-7125Article

The epidemiology of pseudallescheriasis complicating transplantation : nosocomial and community-acquired infectionPATTERSON, T. F; ANDRIOLE, V. T; ZERVOS, M. J et al.Mycoses. 1990, Vol 33, Num 6, pp 297-302, issn 0933-7407Article

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexesPATTERSON, T. F; MINITER, P; DIJKSTRA, J et al.The Journal of infectious diseases. 1989, Vol 159, Num 4, pp 717-724, issn 0022-1899Article

Activity of LY146032 in vitro and in experimental enterococcal pyelonephritisMINITER, P. M; PATTERSON, T. F; JOHNSON, M. A et al.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 8, pp 1199-1203, issn 0066-4804Article

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohortHIEMENZ, J. W; RAAD, I. I; RYAN, D. M et al.European journal of clinical microbiology & infectious diseases (Print). 2010, Vol 29, Num 11, pp 1387-1394, issn 0934-9723, 8 p.Article

Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in Aspergillus fumigatusHERRERA, M. L; VALLOR, A. C; GELFOND, J. A et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 5, pp 1325-1332, issn 0095-1137, 8 p.Article

In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrataOLIVEIRA, E. R; FOTHERGILL, A. W; KIRKPATRICK, W. R et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3544-3545, issn 0066-4804, 2 p.Article